tiprankstipranks
Trending News
More News >
Travere Therapeutics Holds Annual Meeting, Elects Directors
PremiumCompany AnnouncementsTravere Therapeutics Holds Annual Meeting, Elects Directors
27d ago
Buy Rating for Travere Therapeutics: Strong Potential in FSGS Market Amidst Regulatory Milestones and Competitive Edge
Premium
Ratings
Buy Rating for Travere Therapeutics: Strong Potential in FSGS Market Amidst Regulatory Milestones and Competitive Edge
27d ago
Travere falls 14% to $18.10 after FDA does not grant priority review
Premium
The Fly
Travere falls 14% to $18.10 after FDA does not grant priority review
27d ago
Travere Therapeutics announces FDA acceptance of sNDA for Filspari
PremiumThe FlyTravere Therapeutics announces FDA acceptance of sNDA for Filspari
28d ago
Travere Therapeutics: Strong Market Position and Growth Potential Drive Buy Rating
Premium
Ratings
Travere Therapeutics: Strong Market Position and Growth Potential Drive Buy Rating
1M ago
Travere Therapeutics’ Earnings Call: Growth Amid Challenges
Premium
Company Announcements
Travere Therapeutics’ Earnings Call: Growth Amid Challenges
1M ago
Travere, CSL Vifor announce EC approval of Filspari marketing authorization
PremiumThe FlyTravere, CSL Vifor announce EC approval of Filspari marketing authorization
1M ago
TVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
TVTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Tax Day 2025 IRS Payment: Stocks to Consider Buying With the Refund
Premium
Market News
Tax Day 2025 IRS Payment: Stocks to Consider Buying With the Refund
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100